Cerebral Microbleeds and the Safety of Anticoagulation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis
Conclusions
The presence of CMBs increases the risk of ICH during anticoagulant treatment (especially warfarin) in IS patients. Further studies with larger numbers of patients are needed to confirm our conclusions.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Review Articles Source Type: research
More News: Brain | Coumadin | Databases & Libraries | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Neuroscience | Science | Stroke | Study | Warfarin